BDBM482795 US10919862, Example 2-6::[(1 S,5R)-1,3,3-trimethyl-5-(2-{[4-(trifluoromethoxy)phenyl]amino}-1H-imidazo-[4,5-c]pyridin-1-yl)cyclohexyl]methanol
SMILES CC1(C)C[C@H](C[C@@](C)(CO)C1)n1c(Nc2ccc(OC(F)(F)F)cc2)nc2cnccc12
InChI Key InChIKey=VLSKRZTWOMQRGQ-OPAMFIHVSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 482795
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Bayer Pharma Aktiengesellschaft
US Patent
Bayer Pharma Aktiengesellschaft
US Patent
Affinity DataIC50: 1.60E+3nMAssay Description:Levels of (2R)-2-hydroxyglutarate (2HG) were measured in medium of a cell line with overexpression of mutated isocitrate dehydrogenase (mIDH) protein...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Bayer Pharma Aktiengesellschaft
US Patent
Bayer Pharma Aktiengesellschaft
US Patent
Affinity DataIC50: 30nMAssay Description:mIDH1 catalyzes the NADPH-dependent reduction of alpha-ketoglutarate (α-KG) to (2R)-2-hydroxyglutarate (2-HG). NADPH consumption was measured by...More data for this Ligand-Target Pair